2022 annual financial data
Zhengye Biotechnology Holding 2022 Operating income growth
Direct answer
Operating income growth was 25.68%.
Operating income was 65,834,000 CNY and net income was 46,735,000 CNY.
Operating cash flow was 17,335,000 CNY.
Get free Zhengye Biotechnology Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 260,269,000 CNY
- Operating income
- 65,834,000 CNY
- Net income
- 46,735,000 CNY
- Operating cash flow
- 17,335,000 CNY